Furosemide Use in Hypertensive Bedridden Patients

Introduction to Furosemide Guidelines

The European Society of Cardiology recommends diuretics such as thiazides and thiazide-like diuretics (chlorthalidone, indapamide) as first-line treatment for hypertension, often in combination with renin-angiotensin system inhibitors or calcium channel blockers 1.

In patients with moderate to severe renal insufficiency (creatinine clearance <30 mL/min), loop diuretics like furosemide are necessary for effective volume and blood pressure control, as thiazides lose efficacy 2.
Furosemide is specifically indicated when there is edema associated with congestive heart failure, liver cirrhosis, or kidney disease, although the exact context may vary 2.
For resistant hypertension with occult volume expansion, furosemide can be effective as it responds to loop diuretics 2.
In severe heart failure, loop diuretics like furosemide are preferred because they produce greater diuresis, function even with renal impairment, and have linear dose-response characteristics allowing for escalation to high doses 3, 4, 5.

The recommended initial dose of furosemide is 20-40 mg once or twice daily orally, with a maximum dose of 600 mg/day 6.
Furosemide has a relatively short action and usually requires dosing at least twice a day 2.
Alternatively, longer-acting loop diuretics like torsemide can be used 2.

Serum electrolytes, especially potassium, should be monitored as furosemide can cause severe hypokalemia 6, 7.
Renal function, through creatinine monitoring, is crucial as there can be transient worsening of renal function 3, 5.
Fluid balance should be monitored to avoid excessive volume depletion leading to hypotension and renal deterioration 6.

Furosemide should not be used as monotherapy for hypertension in most cases and should be combined with other antihypertensives to avoid activation of adverse compensatory mechanisms 4, 5.
It can be combined with ACE inhibitors or ARBs 1.
Beta-blockers can be added if indicated (coronary disease, heart failure) 1.
An aldosterone antagonist (spironolactone) can be added in resistant hypertension 2, 8.

Hypertension without fluid retention and with normal renal function: thiazides or thiazide-like diuretics (chlorthalidone, indapamide) are preferred 1.
Mild to moderate hypertension without comorbidities: combinations of ACE/ARB with calcium channel blockers or thiazides are recommended 1.

The American Heart Association recommends the combination of hydrochlorothiazide (HCTZ) and furosemide as "sequential nephron blockade" for patients with refractory fluid retention, with HCTZ 25-100 mg once or twice daily plus loop diuretic 9

The combination is most appropriate in heart failure with persistent volume overload despite loop diuretic monotherapy, where sequential nephron blockade is a recognized strategy 9

The guideline-recommended range for sequential nephron blockade is HCTZ 25-100 mg once or twice daily plus loop diuretic 9
Begin with furosemide 20-40 mg once or twice daily (maximum 600 mg/day) and add HCTZ 25-50 mg once or twice daily when furosemide alone is insufficient 9